Find, compare & contact
Methamidophos
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Methamidophos API 10265-92-6?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Methamidophos. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Methamidophos
- Synonyms:
- MONITOR
- Cas Number:
- 10265-92-6
- DrugBank number:
- DB14972
- Unique Ingredient Identifier:
- 8Z083FM94W
General Description:
Methamidophos, identified by CAS number 10265-92-6, is a notable compound with significant therapeutic applications. Methamidophos is under investigation in clinical trial NCT03223753 (Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission).
Categories:
Methamidophos is categorized under the following therapeutic classes: Agrochemicals, Compounds used in a research, industrial, or household setting, Insecticides, Organophosphorus Compounds, Pesticides, Sulfur Compounds, Toxic Actions. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Methamidophos is a type of Insecticides
Insecticides are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to control and eradicate insects that pose a threat to human health, agricultural crops, and livestock. These potent chemicals play a crucial role in protecting our environment, ensuring food security, and preventing the spread of insect-borne diseases.
Pharmaceutical APIs in the insecticide category are designed to target specific insects, disrupting their nervous systems, inhibiting their growth, or interfering with their reproductive capabilities. These APIs are formulated into various insecticide formulations, including sprays, baits, powders, and granules, to suit different application methods and target pests.
Insecticides APIs are developed through rigorous research and development processes, adhering to stringent safety and efficacy standards set by regulatory authorities. These APIs undergo extensive testing to ensure their effectiveness, environmental impact, and potential risks to non-target organisms, such as humans and beneficial insects.
The pharmaceutical industry continually strives to enhance insecticide formulations by developing novel APIs with improved efficacy and reduced environmental toxicity. This includes exploring eco-friendly alternatives, such as biopesticides derived from natural sources like bacteria, fungi, or botanical extracts.
The demand for insecticide APIs is driven by the need to protect public health, agricultural productivity, and the global food supply chain. These APIs play a crucial role in controlling harmful insects, preventing economic losses, and mitigating the transmission of insect-borne diseases. Through ongoing research and innovation, the pharmaceutical industry aims to develop safer and more efficient insecticides that minimize environmental impact while effectively combating insect pests.
